메뉴 건너뛰기




Volumn 45, Issue 2, 2008, Pages 114-120

Antipsychotic treatment in schizophrenia: The role of computerized neuropsychological assessment

Author keywords

[No Author keywords available]

Indexed keywords


EID: 49949111291     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (9)

References (44)
  • 1
    • 25444500137 scopus 로고    scopus 로고
    • Treatment of cognitive dysfunction in schizophrenia
    • Peuskens J, Demily C, Thibaut F. Treatment of cognitive dysfunction in schizophrenia. Clin Ther 2005;27 (Suppl A):S25-S37.
    • (2005) Clin Ther , vol.27 , Issue.SUPPL. A
    • Peuskens, J.1    Demily, C.2    Thibaut, F.3
  • 2
    • 7544244277 scopus 로고    scopus 로고
    • Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS
    • Green, MF, Kerns, SR, Heaton, RK. Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. Schizophr Res 2004;72:45-51.
    • (2004) Schizophr Res , vol.72 , pp. 45-51
    • Green, M.F.1    Kerns, S.R.2    Heaton, R.K.3
  • 3
    • 4344567028 scopus 로고    scopus 로고
    • Cognitive functioning, symptoms, and work in supported employment: A review and heuristic model
    • McGurk SR, Mueser KT. Cognitive functioning, symptoms, and work in supported employment: A review and heuristic model. Schizophr Res 2004;70:147-173.
    • (2004) Schizophr Res , vol.70 , pp. 147-173
    • McGurk, S.R.1    Mueser, K.T.2
  • 5
    • 0037237511 scopus 로고    scopus 로고
    • Insight: Its relationship with cognitive function, brain volume and symptoms in schizophrenia
    • Rossell SL, Coakes J, Shapleske J, Woodruff PW, David AS. Insight: Its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med 2003;33:111-119.
    • (2003) Psychol Med , vol.33 , pp. 111-119
    • Rossell, S.L.1    Coakes, J.2    Shapleske, J.3    Woodruff, P.W.4    David, A.S.5
  • 6
    • 0034864426 scopus 로고    scopus 로고
    • Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: A discriminant function analysis
    • Donohoe G, Owens N, O'Donnell C, Burke T, Moore L, Tobin A, O'Callaghan E. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: A discriminant function analysis. Eur Psychiatry 2001:16:293-298.
    • (2001) Eur Psychiatry , vol.16 , pp. 293-298
    • Donohoe, G.1    Owens, N.2    O'Donnell, C.3    Burke, T.4    Moore, L.5    Tobin, A.6    O'Callaghan, E.7
  • 8
    • 0037449586 scopus 로고    scopus 로고
    • What are the right targets for psychopharmacology?
    • Hyman SE, Fenton WS. What are the right targets for psychopharmacology? Science 2003;299:350-351
    • (2003) Science , vol.299 , pp. 350-351
    • Hyman, S.E.1    Fenton, W.S.2
  • 9
    • 2342475885 scopus 로고    scopus 로고
    • A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: Opening a closed book
    • Mishara, AL, Goldberg, TE. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: Opening a closed book. Biol Psychiatry 2004;55:1013-1022.
    • (2004) Biol Psychiatry , vol.55 , pp. 1013-1022
    • Mishara, A.L.1    Goldberg, T.E.2
  • 10
    • 0037097412 scopus 로고    scopus 로고
    • Another view of therapy for cognition in schizophrenia
    • Carpenter WT, Gold JM. Another view of therapy for cognition in schizophrenia. Biol Psychiatry 2002;51: 969-971.
    • (2002) Biol Psychiatry , vol.51 , pp. 969-971
    • Carpenter, W.T.1    Gold, J.M.2
  • 11
    • 0025222024 scopus 로고
    • The effect of neuroleptics on cognitive and psychomotor function
    • King DJ. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 1990; 157:799-811.
    • (1990) Br J Psychiatry , vol.157 , pp. 799-811
    • King, D.J.1
  • 13
    • 0033021909 scopus 로고    scopus 로고
    • The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis
    • Keefe RS, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis. Schizophr Bull 1999;25:201-222.
    • (1999) Schizophr Bull , vol.25 , pp. 201-222
    • Keefe, R.S.1    Silva, S.G.2    Perkins, D.O.3    Lieberman, J.A.4
  • 14
    • 0035140610 scopus 로고    scopus 로고
    • Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
    • Harvey PD, Keefe RS. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 2001; 158: 176-184.
    • (2001) Am J Psychiatry , vol.158 , pp. 176-184
    • Harvey, P.D.1    Keefe, R.S.2
  • 15
    • 21244448316 scopus 로고    scopus 로고
    • A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
    • Woodward ND, Purdon SE, Meltzer HY, Zald DH. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacology 2005; 8:1-16.
    • (2005) Int J Neuropsychopharmacology , vol.8 , pp. 1-16
    • Woodward, N.D.1    Purdon, S.E.2    Meltzer, H.Y.3    Zald, D.H.4
  • 16
    • 0032977410 scopus 로고    scopus 로고
    • The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
    • Meltzer HY, McGurk SR. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 1999:25:233-255.
    • (1999) Schizophr Bull , vol.25 , pp. 233-255
    • Meltzer, H.Y.1    McGurk, S.R.2
  • 17
    • 33745791791 scopus 로고    scopus 로고
    • Treatment of cognitive deficits in schizophrenia
    • Bowie CR, Harvey PD. Treatment of cognitive deficits in schizophrenia. Curr Opin Investig Drugs 2006;7: 608-613.
    • (2006) Curr Opin Investig Drugs , vol.7 , pp. 608-613
    • Bowie, C.R.1    Harvey, P.D.2
  • 18
    • 34547218379 scopus 로고    scopus 로고
    • Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: A randomized, double-blind 52-week comparison
    • Keefe RSE, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, Lieberman JA. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: A randomized, double-blind 52-week comparison. Am J Psychiatry 2007a;164: 1061-1071.
    • (2007) Am J Psychiatry , vol.164 , pp. 1061-1071
    • Keefe, R.S.E.1    Sweeney, J.A.2    Gu, H.3    Hamer, R.M.4    Perkins, D.O.5    McEvoy, J.P.6    Lieberman, J.A.7
  • 19
    • 33748786261 scopus 로고    scopus 로고
    • Measuring changes in functional status among patients with schizophrenia: The link with cognitive impairment
    • Matza LS, Buchanan R, Purdon S, Brewster-Jordan J, Zhao Y, Revicki DA. Measuring changes in functional status among patients with schizophrenia: The link with cognitive impairment. Schizophr Bull 2006;32: 666-678.
    • (2006) Schizophr Bull , vol.32 , pp. 666-678
    • Matza, L.S.1    Buchanan, R.2    Purdon, S.3    Brewster-Jordan, J.4    Zhao, Y.5    Revicki, D.A.6
  • 20
    • 33845912693 scopus 로고    scopus 로고
    • Is the superior efficacy of new generation antipsychotics an artifact of LOCF?
    • Leucht S, Engel RR, Baum J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF? Schizophr Bull 2007;33:183-191.
    • (2007) Schizophr Bull , vol.33 , pp. 183-191
    • Leucht, S.1    Engel, R.R.2    Baum, J.3    Davis, J.M.4
  • 22
    • 0038148696 scopus 로고    scopus 로고
    • Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: Development, methodology, and rationale
    • Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: Development, methodology, and rationale. Schizophr Bull 2003;29:45-55.
    • (2003) Schizophr Bull , vol.29 , pp. 45-55
    • Keefe, R.S.1    Mohs, R.C.2    Bilder, R.M.3    Harvey, P.D.4    Green, M.F.5    Meltzer, H.Y.6    Gold, J.M.7    Sano, M.8
  • 24
    • 33645230162 scopus 로고    scopus 로고
    • Negative symptoms and cognitive deficits: What is the nature of their relationship?
    • Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative symptoms and cognitive deficits: What is the nature of their relationship? Schizophr Bull 2006;32:250-258.
    • (2006) Schizophr Bull , vol.32 , pp. 250-258
    • Harvey, P.D.1    Koren, D.2    Reichenberg, A.3    Bowie, C.R.4
  • 27
    • 0032697378 scopus 로고    scopus 로고
    • Hobart MP, Goldberg R, Bartko JJ, Gold JM. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: Convergent/discriminant validity and diagnostic group comparisons. Am J Psychiatry 1999;156:1951-1957.
    • Hobart MP, Goldberg R, Bartko JJ, Gold JM. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: Convergent/discriminant validity and diagnostic group comparisons. Am J Psychiatry 1999;156:1951-1957.
  • 28
    • 49949090992 scopus 로고    scopus 로고
    • Guidelines for computer based tests and interpretations. American Psychological Association, 1987.
    • Guidelines for computer based tests and interpretations. American Psychological Association, 1987.
  • 29
    • 0031903740 scopus 로고    scopus 로고
    • Neurocognitive deficits in schizophrenia: A quantitative review of the evidence
    • Heinrichs RW, Zakzanis KK. Neurocognitive deficits in schizophrenia: A quantitative review of the evidence. Neuropsychology 1998;12:426-445.
    • (1998) Neuropsychology , vol.12 , pp. 426-445
    • Heinrichs, R.W.1    Zakzanis, K.K.2
  • 30
    • 0034740718 scopus 로고    scopus 로고
    • Schizophrenia - progressive and massive decline in response readiness by episodes
    • Levander S, Jensen J, Grawe R, Tuninger E. Schizophrenia - progressive and massive decline in response readiness by episodes. Acta Psychiatr Scand 2001;408: 65-74.
    • (2001) Acta Psychiatr Scand , vol.408 , pp. 65-74
    • Levander, S.1    Jensen, J.2    Grawe, R.3    Tuninger, E.4
  • 31
    • 0141669337 scopus 로고    scopus 로고
    • Premorbid IQ and schizophrenia: Increasing cognitive reduction by episodes
    • Eberhard J, Riley F, Levander S. Premorbid IQ and schizophrenia: Increasing cognitive reduction by episodes. Eur Arch Psychiatry Clin Neurosci 2003;253:84-88.
    • (2003) Eur Arch Psychiatry Clin Neurosci , vol.253 , pp. 84-88
    • Eberhard, J.1    Riley, F.2    Levander, S.3
  • 32
    • 0034740721 scopus 로고    scopus 로고
    • Neuropsychological impairments in patients with schizophrenia: Stability and prediction of outcome
    • Grawe RW, Levander S. Neuropsychological impairments in patients with schizophrenia: Stability and prediction of outcome. Acta Psychiatr Scand 2001;408:60-64.
    • (2001) Acta Psychiatr Scand , vol.408 , pp. 60-64
    • Grawe, R.W.1    Levander, S.2
  • 33
    • 0034740719 scopus 로고    scopus 로고
    • Neuropsychological impairment in patients treated with depot neuroleptics: A longitudinal study
    • Tuninger E, Levander S. Neuropsychological impairment in patients treated with depot neuroleptics: a longitudinal study. Acta Psychiatr Scand 2001;408 (Suppl.):75-80.
    • (2001) Acta Psychiatr Scand , vol.408 , Issue.SUPPL. , pp. 75-80
    • Tuninger, E.1    Levander, S.2
  • 34
    • 33747354009 scopus 로고    scopus 로고
    • Standardization and cross-validation study of cogtest an automated neurocognitive battery for use in clinical trials of schizophrenia
    • Barua P, Bilder R, Small A, Sharma T. Standardization and cross-validation study of cogtest an automated neurocognitive battery for use in clinical trials of schizophrenia. Schizophr Bull 2005;31:318.
    • (2005) Schizophr Bull , vol.31 , pp. 318
    • Barua, P.1    Bilder, R.2    Small, A.3    Sharma, T.4
  • 35
    • 0033960819 scopus 로고    scopus 로고
    • Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: A trial of risperidone versus haloperidol
    • Liu SK, Chen WJ, Chang CJ, Lin HN. Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: A trial of risperidone versus haloperidol. Neuropsychopharmacology 2000;22:311-319
    • (2000) Neuropsychopharmacology , vol.22 , pp. 311-319
    • Liu, S.K.1    Chen, W.J.2    Chang, C.J.3    Lin, H.N.4
  • 36
    • 0036268547 scopus 로고    scopus 로고
    • Deficits in sustained attention in schizophrenia and affective disorders: Stable versus state-dependent markers
    • Liu SK, Chiu CH, Chang CJ, Hwang TJ, Hwu HG, Chen, WJ. Deficits in sustained attention in schizophrenia and affective disorders: Stable versus state-dependent markers. Am J Psychiatry 2002; 159:975-982.
    • (2002) Am J Psychiatry , vol.159 , pp. 975-982
    • Liu, S.K.1    Chiu, C.H.2    Chang, C.J.3    Hwang, T.J.4    Hwu, H.G.5    Chen, W.J.6
  • 38
    • 0032570747 scopus 로고    scopus 로고
    • Cognitive processing efficiency in schizophrenia: Generalized versus domain specific deficits
    • Schatz J. Cognitive processing efficiency in schizophrenia: Generalized versus domain specific deficits. Schizophr Res 1998;30:41-49.
    • (1998) Schizophr Res , vol.30 , pp. 41-49
    • Schatz, J.1
  • 39
    • 0034670524 scopus 로고    scopus 로고
    • A new look at reaction time in schizophrenia
    • Gale HJ, Holzman PS. A new look at reaction time in schizophrenia. Schizophr Res 2000:46:149-165.
    • (2000) Schizophr Res , vol.46 , pp. 149-165
    • Gale, H.J.1    Holzman, P.S.2
  • 40
    • 0034670502 scopus 로고    scopus 로고
    • Reaction time, symptom profiles and course of illness in schizophrenia
    • Ngan ET, Liddle PR Reaction time, symptom profiles and course of illness in schizophrenia. Schizophr Res 2000;46:195-201.
    • (2000) Schizophr Res , vol.46 , pp. 195-201
    • Ngan, E.T.1    Liddle, P.R.2
  • 41
    • 32044468522 scopus 로고    scopus 로고
    • The detection of neurocognitive decline in schizophrenia using the Mindstreams Computerized Cognitive Test Battery
    • Ritsner MS, Blumenkrantz H, Dubinsky T, Dwolatzky T. The detection of neurocognitive decline in schizophrenia using the Mindstreams Computerized Cognitive Test Battery. Schizophr Res 2006;82:39-49.
    • (2006) Schizophr Res , vol.82 , pp. 39-49
    • Ritsner, M.S.1    Blumenkrantz, H.2    Dubinsky, T.3    Dwolatzky, T.4
  • 42
    • 33847065797 scopus 로고    scopus 로고
    • Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB
    • Levaux MN, Potvin S, Sepehry AA, Sablier J, Mendrek A, Stip E. Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB. Eur Psychiatry 2007;22:104-115.
    • (2007) Eur Psychiatry , vol.22 , pp. 104-115
    • Levaux, M.N.1    Potvin, S.2    Sepehry, A.A.3    Sablier, J.4    Mendrek, A.5    Stip, E.6
  • 44
    • 0036877453 scopus 로고    scopus 로고
    • Paper-based versus computer-based assessment: Key factors associated with the test mode effect
    • Clariana RB, Wallace PE. Paper-based versus computer-based assessment: Key factors associated with the test mode effect. Br J Educ Technol 2002;33:593-602.
    • (2002) Br J Educ Technol , vol.33 , pp. 593-602
    • Clariana, R.B.1    Wallace, P.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.